NVAX: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/6629a9ad-8a55-4a88-b665-e0d6ebaa3c13/","filing_uuid":"6629a9ad-8a55-4a88-b665-e0d6ebaa3c13","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/6629a9ad-8a55-4a88-b665-e0d6ebaa3c13/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Sara Nuvy","dt_posted":"2026-07-15T23:20:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Thirteenth St, NW","registrant_address_2":"Suite 250 S","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104288,"url":"https://lda.gov/api/v1/registrants/401104288/","house_registrant_id":null,"name":"BALLARD PARTNERS","description":"Government relations and advocacy services","address_1":"601 Thirteenth St, NW","address_2":"Suite 250 S","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SARA NUVY","contact_telephone":"+1 202-800-5620","dt_updated":"2026-10-22T11:27:44.246261-04:00"},"client":{"id":63893,"url":"https://lda.gov/api/v1/clients/63893/","client_id":63893,"name":"NOVAVAX, INC.","general_description":"Biotechnology company","client_government_entity":null,"client_self_select":false,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Guidance navigating vaccine policy.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65360,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BALLARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141688,"prefix":null,"prefix_display":null,"first_name":"JEFF","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":"Former Member US Congress","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}